Cargando…
Does the burden of inflammation determined prospectively in patients with early inflammatory arthritis determine the progression of atherosclerosis?
Autores principales: | Al-Shehhi, WY, Skehan, S, Hefferenan, E, Hughes, F, Veale, DJ, Bresinihan, B, Fitzgerald, O |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834014/ http://dx.doi.org/10.1186/ar1536 |
Ejemplares similares
-
Oncostatin M in rheumatoid arthritis: a key cytokine acts synergistically with other proinflammatory cytokines to promote human cartilage loss
por: Fearon, U, et al.
Publicado: (2005) -
The value of serum type II collagen epitope measurement in assessing early clinical response to treatment with anti-tumour necrosis factor alpha therapy in rheumatoid arthritis
por: Mullan, RH, et al.
Publicado: (2005) -
Anakinra (Kineret) in psoriasis and psoriatic arthritis: a single-center, open-label, pilot study
por: Gibbs, A, et al.
Publicado: (2005) -
Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
por: Avramovič, Mojca Zajc, et al.
Publicado: (2014) -
CVP does not reflect changes in preload when optimal PEEP is determined
por: Tóth, I, et al.
Publicado: (2005)